ImpediMed Secures $15M Growth Capital Funding

New Round Will Assist Gas Commercialization Initiatives on behalf of ImpediMed’s System Innovation for the Discovery and Tracking of Lymphedema

ImpediMed, a leader in clinical innovations to medically keep an eye on and take care of liquid and body make-up, today revealed an arrangement for a five-year $ 15 million development resources center with SWK Holdings, a life science-focused specialized money firm dealing with tiny- and mid-sized commercial-stage firms. Funds increased will certainly offer ImpediMed with moneying versatility and will certainly be utilized to sustain development and commercialization tasks. Armentum Partners worked as the Firm’s special monetary consultant on this purchase.

With this brand-new financing in position, ImpediMed’s resources base is fully equipped to sustain the ongoing implementation of its industrial approach. Consequently, the firm is much better located than ever before to attain its long-lasting objectives and develop considerable worth for its investors.

As a leader in the area of lymphedema discovery and surveillance, ImpediMed provides the only FDA-cleared bioimpedance spectroscopy (BIS) innovation for the scientific analysis of bust cancer-related lymphedema (BCRL)–the SOZO Digital Health Platform ImpediMed’s system is extensively approved and acknowledged for efficient and exact testing of lymphedema, with united state health and wellness payors currently supplying protection for over 258 million covered lives.

Lymphedema, a typical repercussion of cancer cells therapy, is testing to identify prior to signs and symptoms show up. ImpediMed’s SOZO Digital Wellness System utilizes BIS to recognize liquid adjustments early, making it possible for treatment prior to lymphedema ends up being a persistent problem. With expanding fostering in scientific technique and enhancing payor protection, ImpediMed’s cutting-edge technique is changing lymphedema monitoring.

In 2024, the National Accreditation Program for Breast Centers (NABPC) upgraded its certification criteria to consist of lymphedema avoidance programs using BIS as an evidence-based standard for handling lymphedema. The NAPBC is a high quality program of the American University of Surgeons, and recognized programs need to recognize, carry out, and show conformity with certification criteria detailed in Optimum Resources for Bust Treatment This acknowledgment additionally verifies BIS as an essential device in lymphedema monitoring and offers a substantial possibility for ImpediMed to increase its reach, driving more comprehensive fostering of the SOZO Digital Wellness System throughout bust cancer cells facilities nationwide.

” We are pleased with our arrangement with SWK Holdings and the self-confidence they have actually displayed in ImpediMed, along with in the future of our SOZO Digital Health And Wellness System,” stated Dr. Parmjot Bains, MD, Chief Executive Officer and Handling Supervisor at ImpediMed. “SWK’s tried and tested technique of sustaining cutting-edge medical care firms makes them an excellent companion for us as we seek our industrial development approach over the following 5 years. We are positive with business’ instructions, and this was strengthened throughout our due persistance procedure. Along with our existing money gets, this center provides us the moment and financing versatility called for to perform on our service strategy and completely profit from the BCRL possibility.”

” Our company believe that the SOZO Digital Wellness System is transforming exactly how medical professionals evaluate and take care of liquid and body make-up, eventually boosting individual results,” stated JD Tamas, Supervisor of Financing at SWK Holdings. “We are thrilled to offer this resources to sustain ImpediMed’s ongoing objective to boost the lives of people by pressing the borders of what’s feasible in liquid and cells evaluation.”

Regarding SOZO Digital Health And Wellness System

SOZO, the globe’s most sophisticated, non-invasive bioimpedance spectroscopy (BIS) tool, provides a specific picture of liquid standing and cells make-up in much less than 30 secs. Making use of ImpediMed’s BIS innovation, SOZO determines 256 distinct information factors over a vast range of regularities from 3 kHz to 1000 kHz. Outcomes are offered instantly online for very easy information accessibility and sharing throughout a whole medical care system. The FDA-cleared, CE-marked, and ARTG-listed electronic health and wellness system help in the very early discovery of additional lymphoedema, supplies liquid standing for people coping with heart or kidney failing, and can be utilized to keep an eye on and preserve general health and wellness– all on a solitary tool.

Regarding SWK Holdings

SWK Holdings is a life science-focused specialized money firm partnering with tiny- and mid-sized commercial-stage medical care firms. SWK supplies non-dilutive funding to sustain the growth and commercialization of lifesaving and life-enhancing clinical innovations and items. SWK’s distinct funding frameworks offer versatile funding services at an eye-catching price of resources to develop long-lasting worth for all SWK stakeholders. SWK’s services consist of structured financial obligation, conventional aristocracy money making, artificial aristocracy purchases, and possession acquisitions normally varying in dimension from $ 5.0 million to $ 25.0 million

Regarding Armentum Allies

Armentum Partners is a financial investment financial institution committed to aiding medical care and innovation firms accessibility non-dilutive resources. Given that the start of 2023, Armentum has actually increased over $ 3.5 billion for its customers.

Regarding ImpediMed

Established In Brisbane, Australia with United States and European procedures, ImpediMed is a clinical innovation firm that utilizes bioimpedance spectroscopy (BIS) innovation to produce effective information to optimize individual health and wellness. ImpediMed generates the SOZO Digital Health And Wellness System, which is FDA-cleared, CE-marked, and ARTG-listed for several signs, consisting of lymphoedema, cardiac arrest, and protein-calorie poor nutrition, and marketed in pick markets internationally.

In March 2024, the NCCN Medical Method Standards in Oncology (NCCN Standards) for Survivorship remain to reference bioimpedance spectroscopy as the suggested purpose device to evaluate at-risk cancer cells people for very early indicators of lymphoedema. With the SOZO Digital Health And Wellness System and L-Dex, ImpediMed is the only firm to supply FDA-cleared innovation that utilizes bioimpedance spectroscopy for the scientific analysis of lymphoedema. The linked electronic health and wellness system and huge, appealing cancer-related lymphoedema market offer a chance for proceeded solid development with ImpediMed’s SaaS subscription-based service.

For additional information, see impedimed.com.

Initially revealed February 7th, 2025